TNDM 35.91 (+7.94%)
US8753722037Medical Devices & InstrumentsMedical Devices

Tandem Diabetes Care (TNDM) Stock Highlights

35.91 | +7.94%
2024-12-21 03:34:21
Tandem Diabetes Care Inc is a medical device company that develops products for people with insulin-dependent diabetes. The firm has three key insulin pump products. The t:slim Insulin Delivery System can easily fit into a users pocket. The t:flex Insulin Delivery System is used by customers with greater insulin needs. The t:slim G4 Insulin Delivery system is a continuous glucose monitoring enabled pump with a touch screen. Tandem Diabetes also sells pump-related supplies and accessories. Pump sales contribute the majority of revenue. The firm generates virtually all of its revenue in the United States.

Statistics

Range Today
32.46 36.31
Volume Today 4.33M
Range 1 Year
21.85 53.69
Volume 1 Year 392.89M
Range 3 Year
13.82 155.86
Volume 3 Year 973.95M
Range 10 Year
2.14 155.86
Volume 10 Year 2.47B

Highlights

Market Capitalization 2.01B (mid)
Floating Shares 65.11M
Current Price 35.91
Price To Earnings -19
Price To Revenue 2.35
Price To Book 8.45
Earnings Per Share -1.78
Payout Ratio 0%

Performance

Latest +7.94%
1 Month +28.11%
3 Months -19.39%
6 Months -15.23%
1 Year +25.17%
3 Years -74.89%
5 Years -40.68%
10 Years -69.12%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.